Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3734138rdf:typepubmed:Citationlld:pubmed
pubmed-article:3734138lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:3734138lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:3734138lifeskim:mentionsumls-concept:C1512045lld:lifeskim
pubmed-article:3734138pubmed:issue6lld:pubmed
pubmed-article:3734138pubmed:dateCreated1986-9-18lld:pubmed
pubmed-article:3734138pubmed:abstractTextStable-isotope tracer methods are described for answering the following questions about a drug: Does the drug exhibit dose-dependent changes in pharmacokinetic properties? What are the drug's Michaelis constant (Km) and maximum velocity (Vmax) for enzymatic biotransformation; Are the dose-dependent pharmacokinetic changes great enough to be clinically important? and Which routes of the drug's biotransformation are responsible for the drug's dose-dependent pharmacokinetic properties? Illustrative data are provided from tracer studies performed with a drug with dose-dependent pharmacokinetic properties, phenytoin, and a drug that does not exhibit dose-dependent pharmacokinetic properties, phenobarbital. The advantages and disadvantages of the described stable-isotope methods are discussed.lld:pubmed
pubmed-article:3734138pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3734138pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3734138pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3734138pubmed:languageenglld:pubmed
pubmed-article:3734138pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3734138pubmed:citationSubsetIMlld:pubmed
pubmed-article:3734138pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3734138pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3734138pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3734138pubmed:statusMEDLINElld:pubmed
pubmed-article:3734138pubmed:issn0091-2700lld:pubmed
pubmed-article:3734138pubmed:authorpubmed-author:GreenblattD...lld:pubmed
pubmed-article:3734138pubmed:authorpubmed-author:EvansJ EJElld:pubmed
pubmed-article:3734138pubmed:authorpubmed-author:EvansB ABAlld:pubmed
pubmed-article:3734138pubmed:authorpubmed-author:SchumacherG...lld:pubmed
pubmed-article:3734138pubmed:authorpubmed-author:BrowneT RTRlld:pubmed
pubmed-article:3734138pubmed:authorpubmed-author:SzaboG KGKlld:pubmed
pubmed-article:3734138pubmed:issnTypePrintlld:pubmed
pubmed-article:3734138pubmed:volume26lld:pubmed
pubmed-article:3734138pubmed:ownerNLMlld:pubmed
pubmed-article:3734138pubmed:authorsCompleteYlld:pubmed
pubmed-article:3734138pubmed:pagination463-8lld:pubmed
pubmed-article:3734138pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3734138pubmed:meshHeadingpubmed-meshheading:3734138-...lld:pubmed
pubmed-article:3734138pubmed:meshHeadingpubmed-meshheading:3734138-...lld:pubmed
pubmed-article:3734138pubmed:meshHeadingpubmed-meshheading:3734138-...lld:pubmed
pubmed-article:3734138pubmed:meshHeadingpubmed-meshheading:3734138-...lld:pubmed
pubmed-article:3734138pubmed:meshHeadingpubmed-meshheading:3734138-...lld:pubmed
pubmed-article:3734138pubmed:meshHeadingpubmed-meshheading:3734138-...lld:pubmed
pubmed-article:3734138pubmed:meshHeadingpubmed-meshheading:3734138-...lld:pubmed
pubmed-article:3734138pubmed:meshHeadingpubmed-meshheading:3734138-...lld:pubmed
pubmed-article:3734138pubmed:meshHeadingpubmed-meshheading:3734138-...lld:pubmed
pubmed-article:3734138pubmed:articleTitlePharmacokinetics: dose-dependent changes.lld:pubmed
pubmed-article:3734138pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3734138pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3734138pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed